The requirements, which are more far-reaching than industry leaders had expected, could upend commercial health-care markets, which are rife with purposefully complex systems of hidden charges and secret discounts which enable the fleecing of either end users or chronically underfunded government healthcare programs. The price-disclosure initiative has become a cornerstone of the president's 2020 re-election health strategy, despite threats of legal action from industry.